Eli Lilly Stocks Rise as China Approves Orforglipron Weight-Loss Pill

Lilly's oral obesity drug wins Chinese approval, setting up a fight with Novo Nordisk, Pfizer and Innovent in a vast market.

Nov 13, 2026 - 15:00
 0  2
Eli Lilly Stocks Rise as China Approves Orforglipron Weight-Loss Pill
Lilly's oral obesity drug wins Chinese approval, setting up a fight with Novo Nordisk, Pfizer and Innovent in a vast market.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow